Community-Based Peer Support to Reduce Alcohol Use and Improve HIV Care in Pregnant Women in South Africa
Led by University of California, Los Angeles · Updated on 2026-07-02
100
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a peer-led behavioral intervention called Mentor Mothers MM aimed at reducing alcohol use among pregnant and breastfeeding women in South Africa. The study focuses on pregnant and lactating people who use alcohol and may or may not be living with HIV. It addresses the combined risks of alcohol use and HIV, particularly the impact on antiretroviral therapy ART adherence and the prevention of HIV transmission to children. This pilot randomized controlled trial involves 100 pregnant women recruited during antenatal care visits.
Participants will be randomly assigned to either the MM intervention group or an enhanced HIV attention control group. The MM group will receive brief motivational interviewing sessions delivered by trained mentor mothers from the community who have experience with PrEP or ART and who reduced or stopped alcohol use during pregnancy. These sessions, lasting 15-20 minutes each, will be conducted over a 6-month period covering pregnancy and postpartum stages. The control group will receive educational counseling on HIV risk and adherence support during similar clinic visits, with both groups receiving urine testing and biofeedback counseling related to HIV prevention and alcohol use.
During the 6-month study period, participants will attend multiple sessions integrated into routine antenatal care visits. The study team will assess alcohol use reduction through objective measures like phosphatidylethanol PEth levels and self-reports. They will also monitor PrEP initiation and adherence for those without HIV, as well as ART adherence and viral load in participants living with HIV. The study includes regular counseling, urine testing for tenofovir and alcohol metabolites, and ongoing support to understand the interventions impact on health behaviors throughout pregnancy and postpartum.
CONDITIONS
Brief Title
Mentor Moms+ Study
Research Team
D
Dvora L Joseph Davey, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Reported alcohol use during pregnancy within the last 2 months
Lives within 20 kilometers of the study clinic
Able and willing to provide consent to participate
You will not qualify if you...
Individuals who do not meet the above inclusion criteria are excluded
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Intervention Period
Duration - 6 months
Participants attend clinic-based sessions over six months during pregnancy and postpartum. Those in the Mentor Mothers+ group receive motivational interviewing by trained mentor mothers, while the control group receives educational counseling and adherence support. Both groups undergo urine testing and biofeedback counseling related to HIV prevention and alcohol use.
5 to 6 sessions over 6 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Improving HIV Testing in European Hospitals by Introducing Dedicated HIV Teams A Multicenter Study Across Ten Countries
Pilot Study of 1MoreStep A Behavioral Program to Improve HIV Care and Reduce Partner Violence in Black Women Living With HIV
Remote Community Health Worker-Delivered Counseling via mHealth to Reduce Anxiety and Depression in Adults With HIV
Evaluating a New Blood Test to Help Diagnose and Monitor Depression and Psychosis in Adults
Pilot Study to Prevent Frailty in People Living with HIV Aged 65 to 74
Remote Tai ChiQigong Classes to Reduce Depression in Older Adults Living with HIV
Community Screening Study to Reduce Chlamydia and Other STIs in Black Youth Ages 15 to 26 in Orleans Parish
Phase 1 Trial to Assess Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS
Given by IV or SC to Adults Without HIV-1 Aged 18 to 55
Randomized Trial to Improve Muscle Health and Reduce Fat in Veterans with HIV and Obesity
Phase 1 Study of GRAdHIVNE1 Vaccine for Adults With and Without HIV in Southern Africa
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Community-Based Adaptation and Evaluation of a Peer-Led Intervention to Address Alcohol Use and HIV in Pregnant and Breastfeeding Women in South Africa: Protocol for the "Mentor Mothers Plus" Randomized Control Trial.